終値: Jul 24, 16:00:00 GMT-4
アフターマーケット:Jul 24, 20:00:00 GMT-4
No Data Yet
Johnson & Johnson received FDA marketing authorization for its OTTAVA robotic surgical system, clearing the company to compete with Intuitive Surgical in the soft-tissue robotics market.
Intuitive Surgical shares dropped more than 12% in pre-market trading after the company maintained its 2026 da Vinci procedure growth forecast of 13.5% to 15.5%, overshadowing a second-quarter earnings beat.
Intuitive Surgical shares fell 12% after the company reported Q2 2026 earnings with moderated US procedure growth and guided to its slowest expansion in years.
Intuitive Surgical reported Q2 2026 revenue of $2.89 billion, up 19% year-over-year, and adjusted EPS of $2.80, beating Wall Street consensus estimates.
Intuitive Surgical Inc 'in P/E oranı 52.8281 'dir
Mr. David Rosa 2011 'den beri şirketle birlikte olan Intuitive Surgical Inc 'in Chief Executive Officer 'ıdır.
ISRG 'in mevcut fiyatı $336.05 'dir, son işlem günde 0.42% 減少 etti.
Intuitive Surgical Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Intuitive Surgical Inc 'in mevcut piyasa değerlemesi $119.0B 'dir
Wall Street analistlerine göre, 32 analist Intuitive Surgical Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 12 güçlü al, 15 al, 12 tut, 1 sat ve 12 güçlü sat içermektedir